Fig. 1From: Morphoproteomics and biomedical analytics coincide with clinical outcomes in supporting a constant but variable role for the mTOR pathway in the biology of congenital hyperinsulinism of infancyPancreas of infant with CHI and paternal ABCC8 showing nucleomegaly (arrows) in islet cells, with insulin production (Frames a, H&E and b, beta cells with insulin), p-mTOR (Ser 2448) on the plasmalemmal aspect of the acinar cells and positivity in the islet cells with nucleomegaly (Frames c and d), p-Akt (Ser 473), expression in the islet cells with nucleomegaly (Frame e) and contrastively, the negative control (Frame f) (Original magnifications frames a-d and F ×400 and ×600 for frame e)Back to article page